top of page

OUR TEAM

  • 4BIO Capital is a unique team of passionate academics, physician-scientists, industry executives and investment professionals that have come together to address the challenge of chronic disease through early-stage investment in advanced therapies

 

  • With in-depth understanding being the key to success in the rapidly developing therapeutic landscape, 4BIO only invests in advanced therapies, offering investors undiluted access to the fastest growing field of medicine

 

  • The team have not only backed successful advanced therapy companies, but have also contributed to the scientific progress of the field through their own bench research

 

  • 4BIO scientific advisory board includes founders of gene therapy field in academic and hospital settings, leading groups in world centres of academic and clinical excellence

fauchet.png
VENTURE PARTNER, JAPAN
PHILIPPE FAUCHET OBE
4biocapital-26b.jpg
CHIEF OPERATING OFFICER
VASILY FEDORIN PhD
  • White LinkedIn Icon
johnston.png
  • White LinkedIn Icon
INVESTMENT PRINCIPAL
NATALIE JOHNSTON PhD
4biocapital-15b.jpg
MANAGING PARTNER
ANDREW KOZLOV MBA
  • White LinkedIn Icon
yury2.jpg
VENTURE PARTNER, USA
YURY KUKUSHKIN PhD
  • White LinkedIn Icon
kuzmin.png
MANAGING PARTNER
DIMA KUZMIN PhD
  • White LinkedIn Icon
mcgill.png
  • White LinkedIn Icon
FINANCIAL CONTROLLER
EDWARD MCGILL FCA
Alex McKenna - profile pic_edited_edited
INVESTMENT ANALYST
ALEXANDER MCKENNA PhD
  • White LinkedIn Icon
brian_new.png
VENTURE PARTNER, USA
BRIAN MCVEIGH MBA
  • White LinkedIn Icon
4biocapital-38a.jpg
PARTNER
KIERAN MUDRYY LLB
  • White LinkedIn Icon
4biocapital-28a.jpg
OWEN SMITH CPFA
  • White LinkedIn Icon
PARTNER
el1.png
ELEANOR WHATE
  • White LinkedIn Icon
OFFICE MANAGER AND COMPLIANCE ASSISTANT
RusselWong_color.png
RUSSELL WONG LLB
  • White LinkedIn Icon
IN-HOUSE LEGAL COUNSEL
ADVISORY BOARD
KENYA HONDA MD PhD
Prof., Department of Microbiology and Immunology at Keio Univ. School of Medicine; Scientific Co-Founder, Vedanta Biosciences
ADVISOR
ADVISOR
ABBAS HUSSAIN
Former CEO, Vifor Pharma; Global President Pharmaceuticals and Vaccines, GSK
PROF. DIMITRI M
KULLMANN FRCP
​Professor of Neurology,
UCL; Consultant Neurologist, NHNN
ADVISOR
LESZEK LISOWSKI
Associate Professor, Translational Vectorology, University of Sydney;
Co-founder and CTO of LogicBio
ADVISOR
ADVISOR
JOHANNES van der LOO PhD
Adj. Ass. Prof., UPenn School of Medicine; Director, Clinical Vector Core, The Children's Hospital of Philadelphia
CLIVE STANWAY PhD
CSO, Cancer Research Technology; Board Member, Spirogen
ADVISOR
PROF. ADRIAN THRASHER FRCP
ADVISOR
Professor of Paediatric 
Immunology, Wellcome Trust Principal Research Fellow,
UCL Institute of Child Health
bottom of page